Cost-effectiveness of syringe service programs, medications for opioid use disorder, and combination programs in hepatitis C harm reduction among opioid injection drug users: a public payer perspective using a decision tree
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.